What is NDC 70954-135?

70954-135 is the product NDC for Dapsone, Dapsone 25 mg/1 tablet, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dapsone?

45 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dapsone NDC 70954-135 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-135Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0135Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-135-10	7095401351070954013510	30 TABLET in 1 BOTTLE (70954-135-10)Marketed from Jan 15, 2018
70954-135-20	7095401352070954013520	100 TABLET in 1 BOTTLE (70954-135-20)Marketed from Jan 15, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dapsone
Generic name (nonproprietary): dapsone
Active ingredients: Dapsone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.NDC labeler code 70954
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206505
Marketing start: Jan 15, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Sulfones (Chemical structure)
Identifiers: Product ID 70954-135_846ff8b6-d395-4e67-98ea-9dbfd688b97eSPL ID 846ff8b6-d395-4e67-98ea-9dbfd688b97eSPL set ID 57a47368-d1f6-4d61-a2ee-c5f1fe7ff690RxCUI 197557, 197558UNII 8W5C518302UPC 0370954135104, 0370954136200, 0370954135203, 0370954136101
Pharmacologic class: Sulfone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954013510 followed by a unit qualifier and the quantity

Package 70954-0135-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 11, 2025.

Full label on DailyMed (opens in a new tab)

About NDC 70954-135

What is NDC 70954-135?: 70954-135 is the product NDC for Dapsone, Dapsone 25 mg/1 tablet, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dapsone.
What is the active ingredient?: Dapsone.
Who is the labeler?: ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dapsone?: 45 other product NDCs are listed under this name. See all Dapsone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dapsone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dapsone	Dapsone 25 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-534	33342-0534-0733342-0534-11
Dapsone	Dapsone 100 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-535	33342-0535-0733342-0535-11
Dapsone	Dapsone 50 mg/g	GelTopical	Alembic Pharmaceuticals Limited	46708-551	46708-0551-3046708-0551-6046708-0551-90
Dapsone	Dapsone 50 mg/g	GelTopical	Alembic Pharmaceuticals Inc.	62332-551	62332-0551-3062332-0551-6062332-0551-90
Dapsone	Dapsone 25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1979	70771-1979-0170771-1979-03
Dapsone	Dapsone 100 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1980	70771-1980-0170771-1980-03
Dapsone	Dapsone 25 mg/1	TabletOral	Viona Pharmaceuticals Inc	72578-177	72578-0177-0172578-0177-06
Dapsone	Dapsone 100 mg/1	TabletOral	Viona Pharmaceuticals Inc	72578-178	72578-0178-0172578-0178-06
Dapsone	Dapsone 25 mg/1	TabletOral	AvKARE	73190-037	73190-0037-01
Dapsone	Dapsone 25 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-409	69367-0409-0169367-0409-30

All 46 Dapsone NDCs

Other NDCs under ANDA 206505

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206505
Product	Strength	Form · route	Labeler	Product NDC
Dapsone	Dapsone 100 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-136